U.S. markets closed

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
8.46+1.30 (+18.16%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Performance Outlook
Previous Close7.16
Open7.66
Bid8.21 x 3100
Ask8.33 x 1000
Day's Range7.50 - 8.60
52 Week Range7.01 - 30.99
Volume2,157,529
Avg. Volume1,124,922
Market Cap242.512M
Beta (5Y Monthly)-1.98
PE Ratio (TTM)4.90
EPS (TTM)1.73
Earnings DateAug 11, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
37% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ACCESSWIRE

    Co-Diagnostics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Co-Diagnostics, Inc. (NASDAQ:CODX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.

  • Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast
    PR Newswire

    Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast

    Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first-quarter 2021 results on Thursday, May 13, 2021, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. EDT to discuss its financial results with analysts. Management on the call will include Company CEO Dwight Egan and CFO Brian Brown.

  • Co-Diagnostics, Inc. and Partner CRL to Discuss Saliva Testing and Future Applications of PCR in 360Dx Webinar
    PR Newswire

    Co-Diagnostics, Inc. and Partner CRL to Discuss Saliva Testing and Future Applications of PCR in 360Dx Webinar

    Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be accompanying Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Lab ("CRL") in a webinar titled "A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19" on Thursday, April 29 at 2:00 PM EDT.